Nothing Special   »   [go: up one dir, main page]

FR2609397B1 - Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique - Google Patents

Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Info

Publication number
FR2609397B1
FR2609397B1 FR8802162A FR8802162A FR2609397B1 FR 2609397 B1 FR2609397 B1 FR 2609397B1 FR 8802162 A FR8802162 A FR 8802162A FR 8802162 A FR8802162 A FR 8802162A FR 2609397 B1 FR2609397 B1 FR 2609397B1
Authority
FR
France
Prior art keywords
composition
substance
cosmetological
dermatological
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8802162A
Other languages
English (en)
Other versions
FR2609397A1 (fr
Inventor
Marc Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Laboratoires Serobiologiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serobiologiques SA filed Critical Laboratoires Serobiologiques SA
Priority to FR8802162A priority Critical patent/FR2609397B1/fr
Publication of FR2609397A1 publication Critical patent/FR2609397A1/fr
Application granted granted Critical
Publication of FR2609397B1 publication Critical patent/FR2609397B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
FR8802162A 1988-02-23 1988-02-23 Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique Expired - Lifetime FR2609397B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8802162A FR2609397B1 (fr) 1988-02-23 1988-02-23 Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802162A FR2609397B1 (fr) 1988-02-23 1988-02-23 Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Publications (2)

Publication Number Publication Date
FR2609397A1 FR2609397A1 (fr) 1988-07-15
FR2609397B1 true FR2609397B1 (fr) 1991-12-13

Family

ID=9363520

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8802162A Expired - Lifetime FR2609397B1 (fr) 1988-02-23 1988-02-23 Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Country Status (1)

Country Link
FR (1) FR2609397B1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
JP2798287B2 (ja) * 1989-02-08 1998-09-17 ユニチカ株式会社 抗炎症剤
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
FR2652742B1 (fr) * 1989-10-11 1993-10-29 Dominique Vacher Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
DE58907621D1 (de) * 1989-12-15 1994-06-09 Laevosan Gmbh & Co Kg Neue Zuckerderivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
FR2683721B1 (fr) * 1991-11-15 1995-06-09 Inocosm Laboratoires Composition lipidique polaire permettant de vehiculer un agent actif et/ou de le faire penetrer dans une cellule cible.
GB9215768D0 (en) * 1992-07-24 1992-09-09 Agricultural & Food Res Repression of virulent gene expression
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
FR2709061B1 (fr) * 1993-08-17 1996-07-19 Ladislas Robert Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
FR2730409B1 (fr) * 1995-02-15 1997-05-09 Dior Christian Parfums Utilisation des galactolipides, en particulier galactosylglycerides, et des extraits d'origine naturelle contenant ces produits, dans les domaines cosmetiques, pharmaceutique et notamment dermatologique
FR2743296B1 (fr) * 1996-01-10 1998-06-19 Oreal Utilisation d'un polyholoside dans une composition nettoyante ou demaquillante, et composition le comprenant
ES2136379T3 (es) * 1996-01-10 1999-11-16 Oreal Utilizacion de un poliholosido en una composicion limpiadora o desmaquilladora, y composicion que lo comprende.
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US6255295B1 (en) * 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
DE19911053B4 (de) * 1999-03-12 2004-10-28 Biotec Asa Kosmetische und/oder pharmazeutische Zubereitungen
JP4249853B2 (ja) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 経口用皮膚潤い改善剤
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
DE10126396A1 (de) * 2001-05-31 2002-12-05 Beiersdorf Ag Verwendung von Glucosamin zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
ATE401086T1 (de) * 2002-04-30 2008-08-15 Hisamitsu Pharmaceutical Co Zusammesetzung enthaltend trehalose und zink und deren verwendung zur hemmung der hautreizung
FR2863498B1 (fr) * 2003-12-12 2007-04-13 Rocher Yves Biolog Vegetale Nouvelle utilisation de la gomme arabique en tant qu'agent actif en cosmetique
FR2863887B1 (fr) * 2003-12-23 2008-05-16 Jean Noel Thorel Procede d'innoformulation d'une base galenique biocompatible
FR2883473B1 (fr) * 2005-03-25 2012-12-28 Rocher Yves Biolog Vegetale Composition cosmetique comprenant un extrait de gomme chicle
FR2883750B1 (fr) * 2005-04-04 2009-07-31 Virbac Sa Sa Compositions topiques et leurs utilisations
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2906719A1 (fr) * 2006-10-05 2008-04-11 Limousine D Applic Biolog Dite Utilisation de substances agissant sur le derme papillaire pour leur action anti-age.
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
FR2940608B1 (fr) 2008-12-30 2011-04-22 Oreal Utilisation de monosaccharides et composition

Also Published As

Publication number Publication date
FR2609397A1 (fr) 1988-07-15

Similar Documents

Publication Publication Date Title
FR2609397B1 (fr) Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ATE76306T1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
MY101791A (en) New benzimidazole derivatives
FR2737118B1 (fr) Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
FR2608427B1 (fr) Hydrosols de substances pharmacologiquement actives et compositions pharmaceutiques les contenant
ATE55247T1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ZA864002B (en) Gamma-ifn as active substance for inhibiting(preventing)degradation processes in bone
KR870700005A (ko) 하나이상의 활성성분을 함유하는 살충제 조성물
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
HUT50589A (en) Insecticides, acaricides and herbicides containing as active substance derivatives of 2-aryl-1,2,3-triasole
PT82487A (en) Tablets comprising trimethoprim and a sulfonamide
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
PT83556B (de) Biologisch aktive derivate des human-gama-interferons ihre herstellung und arzneimittel die solche derivate enthalten
FR2693105B1 (fr) Composition cosmétique et/ou dermatologique à action dépigmentante contenant un acide di- ou tri-caféoylquinique ou un mélange de ceux-ci.
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
FR2680372B1 (fr) Preparations aqueuses stables d'enzymes et leur utilisation.

Legal Events

Date Code Title Description
ST Notification of lapse